CN: 32-1845/R
ISSN: 2095-6975
Cite this paper:
0
WU Wan-Ying, HOU Jin-Jun, LONG Hua-Li, YANG Wen-Zhi, LIANG Jian, GUO De-An. TCM-based new drug discovery and development in China[J]. Chinese Journal of Natural Medicines, 2014, 12(4): 241-250

TCM-based new drug discovery and development in China

WU Wan-Ying, HOU Jin-Jun, LONG Hua-Li, YANG Wen-Zhi, LIANG Jian, GUO De-An
Shanghai Research Center for Modernization of Traditional Chinese Medicine and National Engineering Laboratory for TCM Standardization Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
Abstract:
Over the past 30 years,China has significantly improved the drug development environment by establishing a series of policies for the regulation of new drug approval.The regulatory system for new drug evaluation and registration in China was gradually developed in accordance with international standards.The approval and registration of TCM in China became as strict as those of chemical drugs and biological products.In this review,TCM-based new drug discovery and development are introduced according to the TCM classification of nine categories.
Key words:    China    China Food and Drug Administration(CFDA)    Traditional Chinese Medicine    Regulatory classification    Drug discovery    Drug development   
Received: 2014-02-13   Revised:
Tools
PDF (392 KB) Free
Print this page
Email this article to others
Authors
Articles by WU Wan-Ying
Articles by HOU Jin-Jun
Articles by LONG Hua-Li
Articles by YANG Wen-Zhi
Articles by LIANG Jian
Articles by GUO De-An
References: